Skip to content

Novel coronavirus pneumonia (COVID-2019) patients' prognosis and their influence on heart and lung function

Novel coronavirus pneumonia (COVID-2019) patients' prognosis and their influence on heart and lung function

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000031751
Enrollment
Unknown
Registered
2020-04-08
Start date
2020-04-01
Completion date
Unknown
Last updated
2020-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case group:N/A
control group:N/A

Sponsors

Wuhan Fourth Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-45 years old men and women; 2. Inpatients; 3. According to the novel coronavirus diagnosis and treatment plan (Seventh Edition), it meets the diagnostic criteria of light and general type and achieves discharge standard after treatment; 4. Signing informed consent.

Exclusion criteria

Exclusion criteria: 1. Participated in other clinical trials 4 weeks before the start of this study; 2. Patients with hypertension, diabetes or other chronic diseases; 3. People with other system basic diseases; 4. Patients with other pathogens before or at the time of admission; 5. Patients who recur after discharge; 6. Pregnant or lactating women; 7. Those who do not sign the informed consent.

Design outcomes

Primary

MeasureTime frame
Colour Sonography;electrocardiogram;Pulmonary function(TLC, FVC, FEV1, DLCO);

Secondary

MeasureTime frame
6MWD;QOL-100;

Countries

China

Contacts

Public Contactzhu pengfei

Wuhan Fourth Hospital

happyzhupengfei@163.com+8613720162185

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026